Cardiovascular Risk in Patients with Chronic Hepatitis C Treated with Direct Acting Antivirals.
Mohammad Said RamadanFilomena BocciaSimona Maria MorettoFabrizio De GregorioMassimo GagliardiDomenico IossaEmanuele Durante-MangoniRosa ZampinoPublished in: Journal of clinical medicine (2022)
In our study, we found that FIB-4 and ASCVD scores exhibited a positive correlation irrespective of time-point after treatment. Larger studies are essential to further investigate the utility of FIB-4 scores in cardiovascular risk assessment.